Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Hexagon Nutrition gets Sebi nod for Rs 600 crores IPO
The company had filed its draft prospectus in December 2021
Poor and middle class benefitted from ‘Jan Aushadhi Kendras’: PM Modi
Modi said the JAKs have reduced the apprehension of people over the cost of medicines
Zydus receives DCGI approval for Oxemia to treat anaemia in CKD patients
OxemiaTM (Desidustat) is an oral tablet formulation which is the first-in-India alternative to injectable…
Government panel recommends permission for phase-III trial of Covovax as booster dose in adults
The Drugs Controller General Of India (DCGI) has already approved Covovax for restricted use in emergency situations in adults on…
Government panel recommends permission for phase-III trial of Sputnik Light vaccine as booster dose
The DCGI had on 4th February granted emergency use permission to Sputnik Light vaccine in India, subject to certain regulatory…
US FDA approves expanded use of Bristol Myers cancer drug Opdivo
The approval was based on data from a late-stage study showing the drug along with chemotherapy improved event-free survival and…
Pfizer Canada recalls BP drug on potential cancer-causing impurity
Long-term exposure to N-nitroso-quinapril at a level above what is considered acceptable may increase the risk of cancer
FDA declines paediatric EUA for Ocugen’s Covaxin
Ocugen had entered into a deal with vaccine maker Bharat Biotech in late 2020, under which it would develop, supply and…
Lupin gets US FDA nod to market generic product
The company has received approval from the United States Food and Drug Administration (FDA) to market the generic version of…
Arthritis drug shown to reduce risk of COVID death in large UK trial
More than 8,000 patients were administered baricitinib in addition to usual care, at random, or usual care alone, as part of the…